Scarica l'app Stockscreener
32.29
3.39%
1.06
Dopo l'orario di chiusura:
32.74
0.45
+1.39%
Precedente Chiudi:
$31.23
Aprire:
$31.5
Volume 24 ore:
291.41K
Relative Volume:
0.87
Capitalizzazione di mercato:
$214.05M
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-19.69
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
-9.51%
1M Prestazione:
-7.21%
6M Prestazione:
+130.64%
1 anno Prestazione:
+140.93%
Intervallo 1D:
$31.50
$33.17
Intervallo di 1 settimana:
$30.48
$35.82
Portata 52W:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Confronta VOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
32.29 | 214.05M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Can machine learning forecast Vor Biopharma Inc. recoveryJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Can Vor Biopharma Inc. stock maintain operating marginsJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Reprogrammed Interchange Llc Sells 48,884 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Sells $2,549,123.94 in Stock - MarketBeat
Vor Biopharma Inc.'s (NASDAQ:VOR) Intrinsic Value Is Potentially 55% Above Its Share Price - simplywall.st
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock - Investing.com
Is Vor Biopharma Inc. stock poised for growth2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Reversal indicators forming on Vor Biopharma Inc. stock2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
What indicators show strength in Vor Biopharma Inc.Portfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
What analyst consensus says on Vor Biopharma Inc. stock2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Is Vor Biopharma Inc. meeting your algorithmic filter criteria2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Vor Biopharma's (VOR) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 70,763 Shares - MarketBeat
Vor biopharma $3.5m stock sale by ten percent owner - Investing.com Australia
Relative strength of Vor Biopharma Inc. in sector analysisJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 02:38:01 - newser.com
Vor biopharma $3.5m stock sale by ten percent owner By Investing.com - Investing.com Australia
Can momentum traders help lift Vor Biopharma Inc.Dividend Hike & Low Risk Investment Opportunities - newser.com
Applying sector rotation models to Vor Biopharma Inc.2025 Key Lessons & Consistent Growth Equity Picks - newser.com
Will Vor Biopharma Inc. bounce back from current support2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Reprogrammed Interchange Llc Sells 7,901 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 32,451 Shares - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 1,400 Shares - MarketBeat
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
76,360 Stock Options — Vor Bio Grants Options at $30.40 and RSUs to New Hires - Stock Titan
Tick level data insight on Vor Biopharma Inc. volatilityJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com
Published on: 2025-10-03 00:08:46 - newser.com
Vor Bio Surges: Analysts See Bright Future - timothysykes.com
Published on: 2025-09-30 05:10:46 - newser.com
Vor Biopharma (VOR) Price Target Increased by 2,942.55% to 36.46 - Nasdaq
Vor Biopharma | EFFECT: Others - 富途牛牛
Vor Bio Announces Late-Breaking Poster Presentation of - GlobeNewswire
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):